OBJECTIVE: To examine whether there are latent trajectory classes in response to treatment and whether they moderate the effects of medication versus psychotherapy. METHOD: Data come from a 1-year randomized controlled trial of 267 low-income, young (M = 29 years), minority (44% Black, 50% Latina, 6% White) women with current major depression randomized to antidepressants, cognitive-behavioral therapy (CBT), or referral to community mental health services. Growth mixture modeling was used to determine whether there were differential effects of medication versus CBT. Depression was measured via the Hamilton Depression Rating Scale (Hamilton, 1960). RESULTS: We identified 2 latent trajectory classes. The first was characterized by severe depression at baseline. At 6 months, mean depression scores for the medication and CBT groups in this class were 13.9 and 14.9, respectively (difference not significant). At 12 months, mean depression scores were 16.4 and 11.0, respectively (p for difference = .04). The second class was characterized by moderate depression and anxiety at baseline. At 6 months, mean depression scores for the medication and CBT groups were 4.4 and 6.8, respectively (p for difference = .03). At 12 months, the mean depression scores were 7.1 and 7.8, respectively, and the difference was no longer significant. CONCLUSIONS: Among depressed women with moderate baseline depression and anxiety, medication was superior to CBT at 6 months, but the difference was not sustained at 1 year. Among women with severe depression, there was no significant treatment group difference at 6 months, but CBT was superior to medication at 1 year.
RCT Entities:
OBJECTIVE: To examine whether there are latent trajectory classes in response to treatment and whether they moderate the effects of medication versus psychotherapy. METHOD: Data come from a 1-year randomized controlled trial of 267 low-income, young (M = 29 years), minority (44% Black, 50% Latina, 6% White) women with current major depression randomized to antidepressants, cognitive-behavioral therapy (CBT), or referral to community mental health services. Growth mixture modeling was used to determine whether there were differential effects of medication versus CBT. Depression was measured via the Hamilton Depression Rating Scale (Hamilton, 1960). RESULTS: We identified 2 latent trajectory classes. The first was characterized by severe depression at baseline. At 6 months, mean depression scores for the medication and CBT groups in this class were 13.9 and 14.9, respectively (difference not significant). At 12 months, mean depression scores were 16.4 and 11.0, respectively (p for difference = .04). The second class was characterized by moderate depression and anxiety at baseline. At 6 months, mean depression scores for the medication and CBT groups were 4.4 and 6.8, respectively (p for difference = .03). At 12 months, the mean depression scores were 7.1 and 7.8, respectively, and the difference was no longer significant. CONCLUSIONS: Among depressed women with moderate baseline depression and anxiety, medication was superior to CBT at 6 months, but the difference was not sustained at 1 year. Among women with severe depression, there was no significant treatment group difference at 6 months, but CBT was superior to medication at 1 year.
Authors: Laura Andrade; Jorge J Caraveo-Anduaga; Patricia Berglund; Rob V Bijl; Ron De Graaf; Wilma Vollebergh; Eva Dragomirecka; Robert Kohn; Martin Keller; Ronald C Kessler; Norito Kawakami; Cengiz Kiliç; David Offord; T Bedirhan Ustun; Hans-Ulrich Wittchen Journal: Int J Methods Psychiatr Res Date: 2003 Impact factor: 4.035
Authors: Madhukar H Trivedi; David W Morris; Ji-Yang Pan; Bruce D Grannemann; A John Rush Journal: Neuropsychiatr Dis Treat Date: 2005-03 Impact factor: 2.570
Authors: Michael P Bancks; Mercedes R Carnethon; Lisa S Chow; Samuel S Gidding; David R Jacobs; Satoru Kishi; Joao Lima; Donald Lloyd-Jones; Jared P Reis; Pamela J Schreiner; Rachel Zmora; Norrina B Allen Journal: J Diabetes Complications Date: 2019-02-06 Impact factor: 3.219
Authors: Laura B Oswald; Rina S Fox; Karly M Murphy; John M Salsman; Stacy D Sanford; Thomas W McDade; David E Victorson Journal: Int J Behav Med Date: 2022-01-20
Authors: Norrina B Allen; Juned Siddique; John T Wilkins; Christina Shay; Cora E Lewis; David C Goff; David R Jacobs; Kiang Liu; Donald Lloyd-Jones Journal: JAMA Date: 2014-02-05 Impact factor: 157.335